Reduced-intensity conditioning with thiotepa, fludarabine and melphalan is an effective regimen for allogeneic transplantation in multiple myeloma

被引：0
|
作者：
Majolino, I
Arana, MG
Riccardi, M
Locasciulli, A
Bacigalupo, A
Di Bartolomeo, P
Scimè, R
Olivieri, A
Narni, F
Bregni, M
De Fabritiis, P
Musso, M
Corradini, P
机构：
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [21] Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT
    Ciurea, S. O.
    Saliba, R.
    Rondon, G.
    Pesoa, S.
    Cano, P.
    Fernandez-Vina, M.
    Qureshi, S.
    Worth, L. L.
    McMannis, J.
    Kebriaei, P.
    Jones, R. B.
    Korbling, M.
    Qazilbash, M.
    Shpall, E. J.
    Giralt, S.
    de Lima, M.
    Champlin, R. E.
    Gajewski, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 (03) : 429 - 436
  • [22] Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT
    S O Ciurea
    R Saliba
    G Rondon
    S Pesoa
    P Cano
    M Fernandez-Vina
    S Qureshi
    L L Worth
    J McMannis
    P Kebriaei
    R B Jones
    M Korbling
    M Qazilbash
    E J Shpall
    S Giralt
    M de Lima
    R E Champlin
    J Gajewski
    Bone Marrow Transplantation, 2010, 45 : 429 - 436
  • [23] Fludarabine and melphalan conditioning with tacrolimus as GVHD prophylaxis for allogeneic stem cell transplant recipients is an effective reduced-intensity combination regimen compared to the conventional regimen
    Osamu Imataki
    Hiroaki Ohnishi
    Yumiko Ohbayashi
    Akira Kitanaka
    Yoshitsugu Kubota
    Toshihiko Ishida
    Terukazu Tanaka
    International Journal of Clinical Oncology, 2009, 14 : 197 - 201
  • [24] Fludarabine and melphalan conditioning with tacrolimus as GvHD prophylaxis is effective reduced-intensity combination regimen for allogeneic stem cell transplant recipients compared to conventional regimen
    Imataki, O.
    Ohnishi, H.
    Kitanaka, A.
    Kubota, Y.
    Tanaka, T.
    Ishida, T.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S93 - S93
  • [25] Fludarabine and melphalan conditioning with tacrolimus as GVHD prophylaxis for allogeneic stem cell transplant recipients is an effective reduced-intensity combination regimen compared to the conventional regimen
    Imataki, Osamu
    Ohnishi, Hiroaki
    Ohbayashi, Yumiko
    Kitanaka, Akira
    Kubota, Yoshitsugu
    Ishida, Toshihiko
    Tanaka, Terukazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (03) : 197 - 201
  • [26] Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Anderlini, Paolo
    Saliba, Rima M.
    Ledesma, Celina
    Plair, Tamera
    Alousi, Amin M.
    Hosing, Chitra M.
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Hagemeister, Frederick B.
    Oki, Yasuhiro
    Neelapu, Saatva
    Romaguera, Jorge E.
    Younes, Anas
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1333 - 1337
  • [27] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Chichra, Akanksha
    Nayak, Lingaraj
    Kothari, Rushabh
    Kalantri, Siddhesh
    Bonda, Avinash
    Gokarn, Anant
    Punatar, Sachin
    Mirgh, Sumeet
    Jindal, Nishant
    Bagal, Bhausaheb
    Kannan, Sadhana
    Mathew, Libin
    Khattry, Navin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (01) : 71 - 79
  • [28] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Akanksha Chichra
    Lingaraj Nayak
    Rushabh Kothari
    Siddhesh Kalantri
    Avinash Bonda
    Anant Gokarn
    Sachin Punatar
    Sumeet Mirgh
    Nishant Jindal
    Bhausaheb Bagal
    Sadhana Kannan
    Libin Mathew
    Navin Khattry
    International Journal of Hematology, 2024, 119 : 71 - 79
  • [29] Prospective Analysis of Bortezomib, Fludarabine and Melphalan As Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation for Multiple Myeloma
    McKiernan, Phyllis
    Siegel, David S.
    Vesole, David H.
    Andrews, Tracy
    Biran, Noa
    Rowley, Scott D.
    Skarbnik, Alan P.
    Pecora, Andrew L.
    Callahan, Jacquelyn
    Ortega, Andrea
    Vendivil, Mariefel
    Kaur, Supreet
    McKenna, Marshall
    Donato, Michele L.
    BLOOD, 2018, 132
  • [30] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
    Nihtinen, A
    Volin, L
    Juvonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
12345